Clinical Trials Browser

Completed × Tadalafil × 1 year × Clear all

Adenocarcinoma, Carcinoma, Pancreatic Neoplasms

NCT03993353 2026-02-12

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

Pyridoxine-dependent epilepsy, Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Esophageal Neoplasms, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms

NCT07333976 2026-01-12

o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

Phase 2 Completed

90 enrolled

Peripheral Nervous System Diseases, Neurotoxicity Syndromes

Clinical Trials

Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer